Total Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $208K | Buy |
+7,423
| New | +$198K | 0.02% | 80 |
|
|
2025
Q3 | – | Sell |
-7,392
| Closed | -$179K | – | 633 |
|
|
2025
Q2 | $179K | Buy |
+7,392
| New | +$172K | 0.03% | 84 |
|
|
2025
Q1 | – | Sell |
-7,603
| Closed | -$202K | – | 79 |
|
|
2024
Q4 | $202K | Buy |
7,603
+183
| +2% | +$4.96K | 0.03% | 73 |
|
|
2024
Q3 | $215K | Buy |
7,420
+74
| +1% | +$2.16K | 0.02% | 64 |
|
|
2024
Q2 | $206K | Buy |
+7,346
| New | +$202K | 0.03% | 63 |
|
|
2023
Q4 | – | Sell |
-6,798
| Closed | -$226K | – | 77 |
|
|
2023
Q3 | $226K | Buy |
6,798
+3
| +0% | +$106 | 0.03% | 60 |
|
|
2023
Q2 | $249K | Buy |
6,795
+245
| +4% | +$9.54K | 0.03% | 59 |
|
|
2023
Q1 | $267K | Hold |
6,550
| – | – | 0.05% | 51 |
|
|
2022
Q4 | $336K | Sell |
6,550
-227
| -3% | -$10.9K | 0.08% | 38 |
|
|
2022
Q3 | $297K | Buy |
6,777
+116
| +2% | +$5.64K | 0.06% | 42 |
|
|
2022
Q2 | $349K | Buy |
6,661
+1
| +0% | +$51 | 0.06% | 43 |
|
|
2022
Q1 | $345K | Buy |
6,660
+116
| +2% | +$6.02K | 0.07% | 50 |
|
|
2021
Q4 | $386K | Sell |
6,544
-263
| -4% | -$13K | 0.06% | 53 |
|
|
2021
Q3 | $293K | Buy |
6,807
+5
| +0.1% | +$222 | 0.07% | 45 |
|
|
2021
Q2 | $266K | Sell |
6,802
-399
| -6% | -$15.5K | 0.05% | 48 |
|
|
2021
Q1 | $235K | Buy |
7,201
+410
| +6% | +$14.6K | 0.07% | 44 |
|
|
2020
Q4 | $250K | Sell |
6,791
-361
| -5% | -$13.2K | 0.05% | 41 |
|
|
2020
Q3 | $241K | Buy |
7,152
+5
| +0.1% | +$175 | 0.07% | 40 |
|
|
2020
Q2 | $222K | Sell |
7,147
-443
| -6% | -$15.1K | 0.08% | 38 |
|
|
2020
Q1 | $235K | Buy |
7,590
+11
| +0.1% | +$375 | 0.07% | 44 |
|
|
2019
Q4 | $282K | Buy |
7,579
+8
| +0.1% | +$285 | 0.05% | 43 |
|
|
2019
Q3 | $258K | Buy |
7,571
+10
| +0.1% | +$364 | 0.05% | 45 |
|
|
2019
Q2 | $265K | Buy |
7,561
+530
| +8% | +$21K | 0.06% | 42 |
|
|
2019
Q1 | $271K | Buy |
7,031
+3
| +0% | +$120 | 0.07% | 41 |
|
|
2018
Q4 | $283K | Buy |
7,028
+3
| +0% | +$125 | 0.09% | 37 |
|
|
2018
Q3 | $294K | Buy |
7,025
+3
| +0% | +$115 | 0.07% | 34 |
|
|
2018
Q2 | $242K | Buy |
7,022
+3
| +0% | +$103 | 0.06% | 39 |
|
|
2018
Q1 | $236K | Buy |
7,019
+4
| +0.1% | +$138 | 0.06% | 40 |
|
|
2017
Q4 | $241K | Buy |
7,015
+3
| +0% | +$102 | 0.07% | 34 |
|
|
2017
Q3 | $238K | Buy |
7,012
+4
| +0.1% | +$129 | 0.08% | 31 |
|
|
2017
Q2 | $223K | Sell |
7,008
-212
| -3% | -$6.69K | 0.07% | 34 |
|
|
2017
Q1 | $234K | Buy |
7,220
+3
| +0% | +$95 | 0.08% | 31 |
|
|
2016
Q4 | $222K | Buy |
+7,217
| New | +$220K | 0.07% | 33 |
|
Other funds holding PFE
VCM
VPM
Total Investment Management's PFE Position: Q1 2026 in Review
Total Investment Management opened a new position in Pfizer (PFE) in Q1 2026: 7,423 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #80 among its holdings. This is a return to the name: Total Investment Management previously reported a position in PFE as recently as Q2 2025.
Total Investment Management first reported a position in PFE in Q4 2016 and has held it in 33 quarters since. The position peaked at $386K in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Total Investment Management held 7,423 shares of Pfizer worth $208K as of Q1 2026.
- Pfizer was a new Total Investment Management position in Q1 2026.
- Pfizer made up 0.02% of Total Investment Management's portfolio in Q1 2026, its #80 holding.
- Total Investment Management first reported a position in Pfizer in Q4 2016 and has held it in 33 quarters since.
- Total Investment Management's Pfizer position peaked at $386K in Q4 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Total Investment Management's 13F filing for Q1 2026, filed 13 Apr 2026.